Key Market Indicators
Sales of beta-blocking medicines in Italy are set to reach €420 million (rounded to €400 million) by 2026. This would mark a growth of 0.8% year on year, according to a new report. Since 2016, the Italian market has grown by 3.8% year on year. In 2021, Germany overtook Italy, with sales of €457.93 million (rounded to €460 million). Italy, Canada and Australia were ranked second, third and fourth respectively.